Monument Therapeutics
Monument Therapeutics is a clinical-stage biotechnology company that applies precision medicine to psychiatry and neurology. The company utilizes proprietary digital biomarkers to identify specific patient groups with similar brain biology to improve drug response rates. Its current pipeline includes small molecule treatments targeting neuroinflammation and cognitive impairment associated with schizophrenia.
Visit websiteCambridge, UK
Biotechnology
Neuroscience
Digital Health
Pharmaceuticals
Funding summary
- Total raised
- €1.0M
- Funding rounds
- 1
Investors in Monument Therapeutics
Investors on record for Monument Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Monument Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors